ALTERATION OF RIBONUCLEOTIDE REDUCTASE IN APHIDICOLIN-RESISTANT MUTANTS OF MOUSE FM3A CELLS WITH ASSOCIATED RESISTANCE TO ARABINOSYLADENINE AND ARABINOSYLCYTOSINE
ALTERATION OF RIBONUCLEOTIDE REDUCTASE IN APHIDICOLIN-RESISTANT MUTANTS OF MOUSE FM3A CELLS WITH ASSOCIATED RESISTANCE TO ARABINOSYLADENINE AND ARABINOSYLCYTOSINE
复制标题
DOI:
10.1007/bf01544746
复制
发表时间:
1981-01-01
期刊:
影响因子:
--
通讯作者:
SENO, T
中科院分区:
文献类型:
--
作者:
AYUSAWA, D;IWATA, K;SENO, T
Aphidicolin-resistant mutants of mouse FM3A [mammary carcinoma] cells were isolated and characterized. Most of the mutants were of a type showing associated resistance to arabinosyladenine, arabinosylcytosine, deoxyadenosine and excess thymidine. This phenotype could also be observed in a variant line selected by resistance to a low level of arabinosylcytosine. In cell-cell hybrids, aphidicolin resistance and cross-resistance behaved as codominant traits. The mutants had an increased dATP pool and decrease ability to incorporate labeled deoxycytidine into macromolecules. Genetic and biochemical evidence suggested that the mutation conferring the pleiotropic phenotype resulted from a change in ribonucleotide reductase activity such that the enzyme was desensitized to the allosteric negative effector dATP. This alteration of the enzyme could account for the marked change in deoxynucleotide pools and for the aphidicolin resistance of the mutants.